Replies to post #748694 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

Most of the examples you provide are after FDA approval. It’s almost 20x revenue potential than UK.

sure but as I said regulation of DCVAXL is being underestimated. Its too simple to just calculate the UK market. Its being regulated that counts.